Lu, H., Liang, B., Zheng, C., Cao, Y., & Xia, X. (2026). Efficacy and safety analysis of TACE combined with lenvatinib and icaritin in unresectable hepatocellular carcinoma with poor performance status. BMC Cancer, 26(1), . https://doi.org/10.1186/s12885-026-16322-6
Παραπομπή σε μορφή Chicago (17η εκδ.)Lu, Haohao, Bin Liang, Chuansheng Zheng, Yanyan Cao, και Xiangwen Xia. "Efficacy and Safety Analysis of TACE Combined with Lenvatinib and Icaritin in Unresectable Hepatocellular Carcinoma with Poor Performance Status." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-16322-6.
Παραπομπή σε μορφή MLA (9th εκδ.)Lu, Haohao, et al. "Efficacy and Safety Analysis of TACE Combined with Lenvatinib and Icaritin in Unresectable Hepatocellular Carcinoma with Poor Performance Status." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-16322-6.